| |
Latest 10 SEC filings (by transaction date) for SAVA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 25/24 | Apr 23/24 | Barry Richard | Indirect Ownership | Common Stock Warrant | M - Exercise or conversion exempt under rule 16b-3 | -117,390 | |
Apr 25/24 | Apr 23/24 | Barry Richard | Indirect Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 176,085 | $22.00 |
Apr 22/24 | Apr 18/24 | Kupiec James William | Direct Ownership | Common Stock Warrant | M - Exercise or conversion exempt under rule 16b-3 | -1,000 | |
Apr 22/24 | Apr 18/24 | Kupiec James William | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,500 | $22.00 |
Apr 17/24 | Apr 17/24 | Schoen Eric | Direct Ownership | Common Stock Warrant | M - Exercise or conversion exempt under rule 16b-3 | -1,000 | |
Apr 17/24 | Apr 17/24 | Schoen Eric | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,500 | $22.00 |
Apr 25/24 | Jan 3/24 | Barry Richard | Indirect Ownership | Common Stock Warrant | A - Grant, award or other under Rule 16b-3(d) | 117,390 | |
Apr 22/24 | Jan 3/24 | Kupiec James William | Direct Ownership | Common Stock Warrant | A - Grant, award or other under Rule 16b-3(d) | 1,000 | |
Apr 17/24 | Jan 3/24 | Schoen Eric | Indirect Ownership | Common Stock Warrant | A - Grant, award or other under Rule 16b-3(d) | 800 | |
Apr 17/24 | Jan 3/24 | Schoen Eric | Direct Ownership | Common Stock Warrant | A - Grant, award or other under Rule 16b-3(d) | 7,920 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for SAVA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 25/24 | Apr 23/24 | Barry Richard | Indirect Ownership | Common Stock Warrant | M - Exercise or conversion exempt under rule 16b-3 | -117,390 | |
Apr 25/24 | Jan 3/24 | Barry Richard | Indirect Ownership | Common Stock Warrant | A - Grant, award or other under Rule 16b-3(d) | 117,390 | |
Apr 25/24 | Apr 23/24 | Barry Richard | Indirect Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 176,085 | $22.00 |
Apr 22/24 | Apr 18/24 | Kupiec James William | Direct Ownership | Common Stock Warrant | M - Exercise or conversion exempt under rule 16b-3 | -1,000 | |
Apr 22/24 | Jan 3/24 | Kupiec James William | Direct Ownership | Common Stock Warrant | A - Grant, award or other under Rule 16b-3(d) | 1,000 | |
Apr 22/24 | Apr 18/24 | Kupiec James William | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,500 | $22.00 |
Apr 17/24 | Apr 17/24 | Schoen Eric | Direct Ownership | Common Stock Warrant | M - Exercise or conversion exempt under rule 16b-3 | -1,000 | |
Apr 17/24 | Jan 3/24 | Schoen Eric | Indirect Ownership | Common Stock Warrant | A - Grant, award or other under Rule 16b-3(d) | 800 | |
Apr 17/24 | Jan 3/24 | Schoen Eric | Direct Ownership | Common Stock Warrant | A - Grant, award or other under Rule 16b-3(d) | 7,920 | |
Apr 17/24 | Apr 17/24 | Schoen Eric | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 1,500 | $22.00 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |